# Rivaroxaban

## XARELTO 15mg

| 藥物代碼           | OXAR                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Xarelto 10 mg Prevention of Venous Thrombosis(VTE) in adult patients undergoing elective hip or knee replacement surgery. Xarelto 15 mg & 20 mg Prevention of stroke & systemic embolism in adult patients w/ non-valvular atrial fibrillation w/ ≧1 risk factors eg CHF, HTN, age ≧75 yr, DM, prior stroke or transient ischaemic attack. Treatment of Deep Venous Thrombosis (DVT) & PE, & prevention of recurrent DVT & PE following an acute DVT in adults. |
| 副作用             | Anemia, dizziness, headache, syncope, eye haemorrhage, tachycardia, hypotension, haematoma, epistaxis, GI disorders, pruritus, pain in extremity, urogenital tract haemorrhage, fever, peripheral oedema, decreased general strength & energy, increased transaminases, postprocedural haemorrhage.                                                                                                                                                             |
| 禁忌               | Hypersensitivity. Clinically significant active bleeding. Hepatic disease associated w/ coagulopathy & clinically relevant bleeding risk including cirrhotic Child-Pugh B & C patients. Pregnancy & lactation.                                                                                                                                                                                                                                                  |
| 懷孕用藥危分級     | 除非治療上需要                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 孕期用藥建議       | No (Limited) Human Data - animal data suggest moderate risk                                                                                                                                                                                                                                                                                                                                                                                                     |
| 附帶說明           | [仿單]無孕婦使用的安全性與有效性資料,動物實驗中顯現生殖性毒性,且本藥可以通過胎盤, 懷孕婦女禁止使用. 具生育能力婦女應採取有效的避孕措施.                                                                                                                                                                                                                                                                                                                         |
| 哺乳期用藥建議     | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                            |
| 附帶說明           | [仿單]無授乳婦使用的安全性與有效性資料,動物實驗中顯現本藥可以分泌致乳汁中, 因此僅能在停止哺乳後使用.                                                                                                                                                                                                                                                                                                                                                            |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

